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Abstract
Several studies propose an influence of chromatin on pre-mRNA splicing, but it is still
unclear how widespread and how direct this phenomenon is. We find here that when
assembled in vivo, the U2 snRNP co-purifieswith a subset of chromatin-proteins, including
histones and remodeling complexes like SWI/SNF. Yet, an unbiased RNAi screen revealed
that the outcome of splicing is influenced by a much larger variety of chromatin factors not
all associating with the spliceosome. The availability of this broad range of chromatin factors
impacting splicing furtherunveiled their very context specific effect, resulting in either inclu-
sion or skipping, depending on the exon under scrutiny. Finally, a direct assessment of the
impact of chromatin on splicing using an in vitro co-transcriptional splicing assay with pre-
mRNAs transcribed from a nucleosomal template, demonstrated that chromatin impacts
nascent pre-mRNP in their competence for splicing. Altogether, our data show that numer-
ous chromatin factors associated or not with the spliceosome can affect the outcome of
splicing, possibly as a function of the local chromatin environment that by default interferes
with the efficiency of splicing.
Author Summary
Splicing is an RNA editing step allowing to produce multiple transcripts from a single
gene. The gene itself is organized in chromatin, associating DNA and multiple proteins.
Some proteins regulating the compaction of the chromatin also affect RNA splicing. Yet, it
was unclear whether these chromatin proteins were exceptions or whether chromatin very
generally affected the outcome of splicing. Here, we show that a subset of chromatin pro-
teins is physically in interaction with the enzyme responsible for RNA splicing. In addi-
tion, several chromatin proteins not found directly associated with the splicing machinery
were also able to influence RNA splicing, suggesting that chromatin compaction very glob-
ally plays a role in splicing. This finding was confirmed using the first in vitro assay com-
bining transcription and splicing in the context of chromatin; this assay showed that
assembling DNA with chromatin proteins influences the efficiencyof splicing.
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Introduction
The transcribed region of almost all human genes contains introns that must be excised from
the pre-mRNA for the exons to be spliced together. This process provides an opportunity to
modify the exon content of the mature mRNA and, as such, must be regarded as a powerful
source of RNA diversity. This alternative splicing is highly regulated and largely depends on a
number of non-snRNP splicing factors that bind site-specifically to sequences present on the
pre-mRNAs.
Over the recent years, a series of observations has suggested that splicing is also influenced
by histone modifying enzymes, readers of histone modifications, and chromatin remodelers
such as SWI/SNF. Here, we will refer to these proteins as chromatin factors. The reasoning
behind a possible impact of these factors on splicing is that splicing is mostly co-transcrip-
tional, and therefore potentially influenced by proteins associated with the transcribed
template.
At least three modifications of histone H3 present inside the coding region of genes, namely
tri-methylation of H3 at lysines 9 (H3K9), 27 (H3K27), and 36 (H3K36), were shown to affect
the outcome of splicing in mammalian cells through their specific recognition by dedicated
chromatin factors [1–4]. A role for intragenic DNA methylation has also been advocated either
as a modification interfering with the recruitment of the boundary protein CTCF that in turns
affects splicing, or as a booster of H3K9 tri-methylation [5,6].
H3K4 tri-methylation, a modification tightly associated with transcription start sites, and
CHD1, a chromatin remodeler able to bind this modification have also been linked to the regu-
lation of splicing [7]. That study showed the first interaction between a chromatin factor
(CHD1) and components of the U2 snRNP, and suggested that this snRNPmay function as a
bridge between chromatin and splicing machineries. Other observations have since given sup-
port to that idea. In particular, immuno-purification of the splicing factor PRP40A from HeLa
cell nuclear extracts brings down U2 snRNP subunits together with SWI/SNF subunits and
several CHD family members [8]. Furthermore, experiments in Schizosaccharomyces pombe
have revealed genetic interactions betweenU2 and SWI/SNF subunits [9]. Finally, the U2
snRNP subunit SF3B1 was shown to interact directly with chromatin [10], with Polycomb
group proteins [11], and with theWSTF-SNF2h chromatin remodeling complex [12].
The U2 snRNP is composed of the U2 snRNA and numerous proteins, including 7 Sm pro-
teins, U2-A’, U2-B”, and the components of the SF3A and SF3B complexes. It associates with
the lariat branch site near the 3’ end of the intron via base-pairing between the U2 snRNA and
the pre-mRNA. This binding is primed by the association of the U1 snRNP to the 5’ end of the
pre-mRNA and the binding of SF1 and U2AF to the branch site and the polypyrimidine track,
respectively.
The U1 and U2 snRNPs together with the pre-mRNA form the A complex or pre-spliceo-
some. In most cases, the positioning of this complex defines the exon-intron borders or splice-
sites that will be used [13].
The A complex then associates with the U4/U5/U6 tri-snRNP, and finally U1 and U4 are
evicted to generate an active B complex. This complex catalyzes a first transesterification reac-
tion that cleaves between the upstream exon and the intron.
Finally, the splicing reaction is complete by a second transesterification reaction that rejoins
the two exons and releases the intron as a lariat [14].
In the present study, we wished to investigate to what extend the U2 snRNP was a pivot in
connecting splicing to chromatin. To address this issue, we developed several complementary
approaches. First, we captured spliceosomes assembled before the second transesterification
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reaction and showed the presence within this complex of chromatin and transcription factors.
In a second inverse approach, we systematically depleted human tissue culture cells from
known chromatin factors and examined the impact on a splicing reporter. Finally, we com-
bined for the first time chromatin, transcription, and splicing in a same in vitro reaction to esti-
mate the direct impact of chromatin on the splicing reaction. Together, our observation
documents a direct and extensive impact of chromatin factors on splicing with however an out-
come that remains difficult to predict possibly because of the influence of chromatin.
Results
U2 snRNP anchored to spliceosomes in the cell captures chromatin
components
U2 is the only snRNP present in every spliceosome complexe. Therefore, to capture chromatin
factors associated with the spliceosome in the course of an in vivo splicing reaction, we devel-
oped a new procedure for proteomic analysis of the U2 snRNP.
Earlier protocols for the purification of spliceosomesmostly relied on in vitro assembly of
the splicing machinery on a tagged reporter RNA. The subsequent capture of the tagged RNA
did not result in co-purification of any chromatin factor, possibly because, by design, the
approach captured only spliceosomes assembled independently of transcription.
Here, to capture in vivo-assembledU2 complexes, we engineeredHeLa S3 cells to express a
FLAG-V5-tagged version of U2-B” (FV5-U2-B”), a constitutive component of the U2 snRNP
(Fig 1A). Immuno-purifications in the absence of any cross-linking showed that the recombi-
nant FV5-U2-B” was incorporated into both the 12S and 17S forms of U2 snRNP (S1A Fig and
S1B Fig). Nuclear extracts prepared from the FV5-U2-B”-expressing cells (NEB”) also retained
full competence for splicing of a 32P-labelled AdML reporter pre-mRNA in vitro (S1C Fig com-
pare lanes 1–3 and 6–8), and immuno-precipitation of FV5-U2-B” from the in vitro splicing
reactions led to enrichment in both un-spliced and spliced AdML reporter RNA (S1C Fig,
lanes 9–10), consistent with the presence of the U2 snRNP in all intermediate complexes of
spliceosome assembly.
We then set up to examine the protein composition of complexes associated with FV5-
U2-B” during the splicing reaction. To accumulate pre-spliceosome (complex A) and spliceo-
some (complex B), NEB” was supplemented with ATPγS, an ATP analog which blocks the
splicing reaction before the second transesterification step [15]. To facilitate the tracing of
splicing complexes engaged in splicing reactions, NEB” with ATPγS was further incubated for
40 min. at 30°C with 32P-labelled AdML reporter pre-mRNA. This tracing allowed to confirm
accumulation of complexes A and B in our experimental conditions (Fig 1B).
The A and B complexes assembled in vivo on non-radioactive pre-mRNAs together with
those assembled in vitro on the tracer pre-mRNA were resolved from non-specific ribonucleo-
particles (H complex) by gel-filtration chromatography and used for immuno-purification
with anti-FLAG antibody (Fig 1C).
As revealed by mass spectrometry, this procedure resulted in isolation of most previously
characterized splicing factors (187 out of 284), including all the core components of the spli-
ceosome and many regulators of splicing (S1 Table). In addition, the FV5-U2-B”-associated
complexes contained a large number of chromatin factors (Table 1).
Importantly, endogenous/taggedU2-B” and two chromatin factors (CHD4 and SMARCC1)
co-sedimentedwith both the H complex and the spliceosome (S1D Fig). The presence of U2
snRNP subunits, splicing factors, and chromatin factors in both the H complex- and the spliceo-
some-fractionswas confirmedby western blotting (Figs 1D, lanes 2 & 3 and S1E, lanes 1 & 2).
Yet, splicing and chromatin factors were efficiently co-immunoprecipitated with FV5-U2-B”
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Fig 1. Purificationof spliceosomecomplexes associatedwith the U2 snRNP. (A) Detection by western blot of indicated splicing factors in nuclear
extracts fromHeLa S3 cells eitherWT (NE) or stably transducedwith FV5-U2-B (NEB”). (B) Comparison of the kinetic and quality of spliceosome assembly
on a radiolabeled AdML pre-mRNA reporter in the presence of either ATP (lanes 1–3) or ATP-γS (lanes 4–8). Spliceosome complexes A and B were
resolved from unspecific RNP (H complex) on a native gel. (C) Spliceosomecomplexes were purified by Sephacryl-S500 gel filtration from an in vitro-
splicing reaction composed of NEB” and radiolabeledAdML reporter incubated for 45 min in the presence of ATP-γS. Fractions with spliceosome and H
complexes selected for anti-FLAG immunoprecipitation are indicated. Degraded RNAs and free proteins appear in fractions 68 to 80. (D) Spliceosome
complexes anchored to the U2 snRNP. NEB”, gel-filtration fractionswith either spliceosome (Splic.; lane 2) or H complex (H; lane 3), and the product of the
anti-FLAG immunoprecipitation (lanes 4 and 5) were analyzed by western blot using the indicated antibodies. See also Table 1 and S1D and S1E Fig.
doi:10.1371/journal.pgen.1006318.g001
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Table 1. Chromatin factors identifiedby mass spectrometry as associated physically with the spliceosome.
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Chromatin RemodellingFactors PBRM1 BAF180 55193 181 27 24 -307.4
SMARCC2 BAF170 6601 132.8 23 36 -263.5
SMARCA4 BRG1 6597 188 21 23 -224.6
SMARCD1 BAF60A 6602 58.2 11 34 -135.3
BRD7 BRD7 29117 74.1 10 21 -97.3
SMARCC1 BAF155 6599 122.8 10 20 -183.8
CHD4 CHD4 1108 217.9 9 8 -81
ACTL6A BAF53A 86 43.2 8 40 -76.9
SMARCE1 BAF57 6605 46.6 8 32 -101.9
SMARCA1 SNF2L 6594 121.1 6 8 -45.8
SMARCD2 BAF60B 6603 58.9 6 23 -54.6
SMARCA2 Brm 6595 181.2 5 7 -128.4
SMARCB1 BAF47 6598 44.1 4 14 -42.2
ARID1A BAF250 8289 218.2 3 4 -18.2
CHD7 KAL5 55636 335.7 2 1 -11.1
BPTF NURF301 2186 324.9 2 1 -10.7
BRD1 BRPF1 23774 119.4 2 4 -19.2
CBX2 CDCA6 84733 56 2 7 -12.2
CHD5 CHD5 26038 222.9 2 2 -43
ARID1B BAF250B 57492 237.5 1 1 -1.6
MSL3 MSL3 10943 58.2 1 2 -1.7
POLE3 CHRAC17 54107 16.8 1 9 -1.6
SMARCA5 SNF2H 8467 121.8 1 2 -27.6
Histone PTMs regulators Ac HDAC2 RPD3 3066 55.3 6 20 -51.8
Me WBP7 MLL4 9757 293.3 5 4 -35.3
Ac KAT6B MYST4 23522 199.7 4 7 -29.4
Me EHMT1 GLP1 79813 86.6 4 8 -27.3
Ph ZMYND8 RACK7 23613 128.3 3 3 -23.9
Ac BRD8 SMAP 10902 94.2 3 6 -21.2
Me MLL3 HALR 58508 541 3 1 -18.8
Me MLL2 KMT2D 8085 593 3 1 -18.7
Ac HDAC1 SMAP 10902 55.1 2 8 -38.8
Me SETD1A KMT2F 9739 185.9 2 2 -14
Ub SHPRH SHPRH 257218 193 2 2 -11.6
Ac MORF4L1 MRG15 10933 41.4 2 11 -13.7
Me EHMT2 G9A 10919 128.9 2 3 -13
Ph BAZ1B WSTF 9031 170.8 2 1 -10.9
Me DOT1L KMT4 84444 164.8 1 1 -12.2
Ac CDYL CDYL1 9425 60.6 1 3 -2.3
Transcriptional regulators SNW1 SKIP 22938 61.5 16 42 -161.7
SAFB HET 6294 102.7 6 17 -84.4
NCOR2 SMRT 9612 272.7 5 4 -39.9
SIN3A SIN3A 25942 145.1 4 4 -38.6
GATAD2A GATAD2A 54815 68 4 9 -34.1
NCOR1 TRAC1 9611 270 4 3 -35.7
ZBTB4 ZNF903 57659 105 3 12 -18.9
HP1BP3 HP1BP3 50809 61.2 2 6 -11
DMAP1 EAF2 55929 53 2 5 -12.9
SIN3B SIN3B 23309 133 2 3 -10.9
TAF1 TAFII250 6872 212.5 2 2 -10.7
RB1 OSRC 5925 106.1 2 4 -10.4
COBRA1 NELFB 25920 65.7 1 3 -3.6
CBX3 HP1γ 11335 20.8 1 9 -1.9
ZBTB33 ZNF-kaiso 10009 74.4 1 2 -1.6
TRIM28 KAP1 10155 88.5 1 3 -2
(Continued)
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only when using the spliceosome-fractions (Figs 1D, lanes 4 & 5 and S1E, lanes 3 & 4). This indi-
cated that these factors were physically together with the U2 snRNP only in the context of an
assembled spliceosome. The Polycomb group protein PHC1 that was present in both the H com-
plex- and spliceosome-fractionsbut not detected in the mass spectrometrydata, was not co-
immunoprecipitated with FV5-U2-B” and is shown as a negative control (S1E).
As will be further discussed below, the chromatin factors associated with FV5-U2-B” were
enriched in subunits of chromatin remodeling complexes such as SWI/SNF, but included also
readers and writers of histone modifications, and rather surprisingly histones.
Altogether, these data showed that U2-snRNPs incorporated into splicing complexes assem-
bled onto pre-mRNAs during or immediately after their transcription, are physically associated
with chromatin factors.
Table 1. (Continued)
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Nucleosome components HIST1H4L H4 8368 11.4 2 33 -21.5
HIST3H2BB H2B 128312 13.9 2 25 -12
HIST1H1T H1 3010 22 1 14 -1.8
H2AFY2 H2A2 55506 40 1 4 -2.1
HIST1H2BA TSH2B 255626 14.2 1 27 -1.9
Others MTA2 MTA1L1 9219 75 15 31 -174.3
ACIN1 ACINUS 22985 150.5 8 8 -69.8
RBBP4 NURF55 5928 47.6 6 24 -59.7
SMC1A SMC1 8243 143.1 6 8 -46.7
MBD3 MBD3 53615 32.8 4 17 -29
PARP4 PH5P 143 192.5 3 3 -19
NASP FLB7527 4678 78.4 3 6 -19.4
C14ORF43 ELM2 91748 114.9 2 3 -12.1
BRCA2 FAD 675 384 2 1 -11.1
TOX4 LCP1 9878 66.2 2 18 -12.1
LIG4 LIG4 3981 103.9 1 1 -1.8
MBD3L2 MBD3L2 125997 23 1 6 -1.9
EIF2C1 EIF2C 26523 97.2 1 2 -1.8
PRMT8 HRMT1L3 56341 45.3 1 2 -1.8
PRMT5 HRMT1L5 10419 71.3 1 2 -1.8
HERC2 SHEP1 8924 526.9 1 0 -1.8
BRCA1 IRIS 672 202.2 1 1 -2
DICER1 Dicer 23405 208.3 1 1 -2.4
C6ORF130 C6orf13 221443 17 1 8 -2.1
EIF2C2 AGO2 27161 97.1 1 2 -2.7
TSPYL1 TSPYL 7259 49.2 1 9 -2.4
TNKS1BP1 TAB182 85456 181.7 1 1 -1.9
BRIP1 BACH1 83990 140.8 1 1 -10.8
List of chromatin factors associated with spliceosome complexes immunopurified from gel-filtration fractions through the tagged U2 snRNP. Mass
spectrometry was carried out like in [42]. Proteins are grouped in five pools as in Fig 2C; black boxes designate factors also identified in the siRNA screen.
For each gene, the table provides the name, frequently used alternative names, the NCBI identification gene number (NCBI Gene Id.), the molecular weight
(Mr), the number of unique peptides, the percentage of protein coverage, and a measure of the statistical confidence (Log(e)). In the pool of histone PTM
regulators, the modifications are reportedas follows: acetylation (Ac), methylation (Me), phosphorylation (Ph), ubiquitination (Ub). Data shown was compiled
from two independent experiments.
doi:10.1371/journal.pgen.1006318.t001
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Identificationof chromatin factors active in the regulation of splicing
We next questioned whether the chromatin factors associated with U2-snRNPs were represen-
tative of the population of chromatin factors affecting pre-mRNA splicing. To reach a global
insight on chromatin factors relevant for the regulation of splicing, we carried out an unbiased
RNAi screen of virtually every known human chromatin factor, using a CD44-based splicing
reporter. This ponasterone-inducible reporter translates transcriptional activity into Firefly-
luciferase luminescence, while inclusion of CD44 alternative exons v4-v5 allows for in-frame
splicing of the RenillamRNA and thereby produces Renilla-luciferase activity (Fig 2A). This
reporter (v4-v5—ren) and a variant missing the v4-v5 genomic sequence (int—ren–no in-
frame splicing of Renilla) were inserted randomly into the genome of 293 EcR cells, a cell line
not expressing the endogenous CD44 gene (S2A Fig).
Comparative analysis of two clonal cell lines having integrated either v4-v5—ren or the con-
trol int—ren construct confirmed that Renilla enzymatic activity was detected only when v4-v5
exons were present in the reporter mRNA (S2A and S2B Fig, light-grey bars). Furthermore,
depletion of Sam68, a regulator of CD44 splicing [16], led to a decrease in splicing of v4-v5,
which correlated with a decrease in the Renilla over Firefly luminescence ratio (referred to as
the R/F ratio—S2C Fig). Thus, splicing of our reporter was regulated in a manner comparable
to that expected for exons v4-v5 in the context of the endogenous CD44 gene. At note, our
reporter is not insensitive to eventual changes in translation efficiencies.
We then challenged the reporter with a library of 1155 siRNAs targeting 375 different genes
predicted or known to encode regulators or components of chromatin (an average of 3 siRNAs
per target—Fig 2B and S2 Table). To take experimental variations into account, we compared
the R/F ratio obtained with each siRNA to that obtained with control siRNAs (unrelated and
Sam68, as negative and positive controls, respectively). Thus, a siRNA was considered a hit
when its transfection resulted in a variation of the R/F ratio equal to at least 50% of that
observedwith Sam68 siRNA. A gene was selectedwhen at least two siRNAs qualified as hits.
Using this criterion, we identified 62 chromatin factors potentially influencing splicing,
including 11 factors for which the R/F ratio was affected by all three siRNAs (triple hits—Fig
2C grey case). Among the 62 factors, ING2 and MLL4 were previously identified in another
siRNA screen for chromatin factors affecting splicing of a reporter construct (S3 Table) [17].
The 11 “triple hits” were retested in the conditions of the screen, and we confirmed by RT-
qPCR that they all had an impact on splicing of v4-v5 exons into the reporter mRNA (S2D and
S2E Fig).
Comparing the outcome of the proteomic analysis of the FV5-U2-B”-associated complexes
and that of the siRNA screen revealed an overlap essentially limited to histones and chromatin
remodeling factors (Table 1, lines with black squares). In particular, subunits of the BAF complex
and its variant Brm-Sin3a-HDAC were present in both screens (Fig 2D). SNF2H and its partner
Pole3 in the human Chrac complex were also identified in both screens (Fig 2E), as were several
members of the CHD family. In contrast, histone modifying enzymes and transcriptional regula-
tors identified in the siRNA screen were predominantly absent from theMS data.
Chromatin factors regulating splicing are not all associated with U2
We next wished to assess the actual impact of the identified chromatin factors on splicing of
endogenous genes. These validation experiments were carried out on not previously character-
ized “triple hits” from the siRNA screen and five additional “double hits” selected for their
association with chromatin remodeling complexes (CHD5, SMARCAD1, SIN3a, SMARCA5,
and POLE3). Among these 14 factors, 7 were found associated with the U2-snRNP (CHD7,
ChromatinModulates IntronRemoval
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Fig 2. A high-throughput siRNA screen for chromatin factors that affect splicing. (A) Diagram of the bi-
cistronic v4-v5–ren and int-renminigene reportersused to follow splicing by luminescence. Rectangles represent
exons, stem-loop structures represent InternalRibosomeEntrySites (IRES). Splicing regulation leading to a
functional Renilla is indicated in Green, while those producing to a non-functional Renilla are marked in Red (B)
Outline of the procedure used to screen a library of siRNAs targeting375 chromatin factors. Each gene was
targetedwith an average of 3 individual siRNAs, tested in duplicates. (C) List of chromatin factors modulating
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POLE3, SIN3A, HDAC2, CHD5, SMARCA5, BRD7), while the remaining 7 were not (TAF5,
H2AFx, TADA2beta, HAT1, PHC1, RCF1, and SMARCAD1).
Depletion of 8 of these factors with siRNAs resulted in reduced usage of the endogenous
CD44 variant exons v4-v5 in HeLa cells, a cell line naturally expressing CD44 (Figs 3A, S3A
and S3B). In contrast, depletion of CBX8, HDAC3, and NCAPD2, three chromatin factors
identified neither in the U2 snRNP proteomic study nor in the siRNA screen, did not affect
usage of the v4-v5 exons (S3C Fig).
We next examined the effect of the depletion of the 14 selected chromatin factors on several
exons previously described as being particularly sensitive to U2 snRNP activity [18], reasoning
that factors associated with the U2 snRNP were likely to affect the inclusion of these exons
(Figs 3B, S3D and S3E). In this series of experiments, depletion of 13 chromatin factors, present
or not in the FV5-U2-B”-associated complex, affected inclusion of multiple alternative exons.
Only Brd7 was found not to affect any exon. The 13 chromatin factors active on the U2
snRNP-sensitive exons had no effect on constitutive exons in the RAC1 or the PSMG1 genes,
indicating that overall splicing activity was not affected (S3F Fig); neither did their depletion
affect expression of hnRNPU, an hnRNP that influence the maturation and activity of the U2
snRNP [18]. We also observedno correlation between the effect of the 13 chromatin factors on
splicing and that on expression of several essential splicing regulators, some of which had puta-
tive binding sites in the exons we examined (SRSF1, SRSF3, SRSF4, SRSF5, SRSF6, and
hnRNPA1, S3G Fig).
These experiments showed that an unexpectedlywide range of chromatin factors can
impact on the outcome of splicing, although some were not identified by proteomic as physi-
cally interacting with the U2 snRNP in spliceosome complexes. Yet, sensitivity of an exon to
levels of U2 appears as a good predictor of its sensitivity to chromatin, suggesting that U2 is
responsive to chromatin-born information. Finally, we note that depletion of the various chro-
matin factors resulted in either increased or decreased inclusion depending on the exon under
scrutiny, revealing that the impact of chromatin factors varies from one exon to the other, pos-
sibly as a function of local levels of chromatin compaction or histone modifications.
Chromatinmodulates splicing efficiency
To gain information on how chromatin may influence splicing, we next developed an in vitro
assay (seeMethods and Fig 4A), which allowed a side-by-side comparison of splicing per-
formed by (i) the spliceosome alone, (ii) splicing coupled to transcription, and (iii) splicing
coupled to both transcription and chromatin decondensation.
We chose a reporter construct based on Drosophila Fushi tarazu (Ftz) exon 1 and 2, previ-
ously used in an in vitro system coupling RNAPII transcription to spliceosome assembly [19].
This splice reporter was put under the control of a CMV promoter, or a chimeric promoter
with five GAL4 binding sites located upstream of a minimal Adenovirus E4 promoter (Gal4-E4
—S4A Fig). For the latter, transcriptional activity was achieved by supplementing all in vitro
reactions with the chimeric transcriptional activator Gal4-VP16.
Co-transcriptional splicing of the pre-mRNA synthesized from the CMV-Ftz DNA template
was more efficient than splicing of an identical pre-synthesized and capped pre-mRNA,
splicing of the v4-v5-ren reporter in 293 EcR cells. The 63 hits of the siRNA screen are grouped in five categories
according to the “String”database (string-db.org). Associated post-translationalmodifications (PTMs) are
indicated to the left of the gene names: Acetylation (Ac), Methylation (Me), Phosphorylation (Ph). Each gene is
designated by its name and its NCBI identification number (NCBIGene Id.). (D and E) Schematic display of
BRM-sin3A-HDAC and huCHRAC complexes highlighting the subunits identified by proteomic or by the siRNA
screen.
doi:10.1371/journal.pgen.1006318.g002
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Fig 3. Chromatin factors affect the regulationof endogenous splicing. SiRNAs targeting 14 chromatin factors and
identified as affecting splicing of v4-v5-ren in 293-ECRcells were transfected into HeLa cells as well as siRNA targeting
controls. (A) RadiolabeledRT-PCR was then used to examine splicing of exons v4-v5 from endogenous CD44 and exons 2
and 3 fromSam68. The chromatin factors identified by mass spectrometry are highlightedwith asterisks. (B) Graphs
ChromatinModulates IntronRemoval
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consistent with earlier observations ([19] and Fig 4B, compare lanes 2 and 5). This difference
in splicing efficiencywas less discernible when the Gal4-E4-Ftz DNA template was used
instead (compare Fig 4B lane 2 and Fig 4C lane 4), possibly reflecting previously described
influence of promoter sequences on splicing [20,21].
To then evaluate the impact of nucleosomes on our co-transcriptional splicing assay, the
DNA template was chromatinized by combining purified recombinant human chromatin
assembly complex ACF (SMARCA5 and BAZ1A) and histone chaperone NAP-1 (NAP1L1)
with purifiedHeLa core histones in the presence of ATP [22]. The regularity of nucleosome
spacing on the DNA template was confirmed by micrococcal nuclease digestion, which
revealed protected DNA fragments corresponding to a ladder of mono-, di- and oligo-nucleo-
somes, mimicking the nucleosome periodicity observedwith native chromatin (S4B Fig).
Chromatinization of the CMV-Ftz DNA template strongly reduced transcription, making
assertion of the splicing efficiencyvirtually impossible (Fig 4B, compare lanes 4, 5 and 6, 7).
Chromatinization also reduced transcription from the Gal4-E4-Ftz DNA template, although
less radically, and transcriptional activity was partially recovered (approx. 50% of that observed
on naked DNA) by supplementing the in vitro reactions with acetyl coenzymeA (CoA), and
sodium butyrate (NaB) (Fig 4C, compare lanes 9 and 18). Acetyl CoA, a co-factor of histone
acetylases, and sodium butyrate, an inhibitor of histone deacetylases, favor histone acetylation
and thereby participate in licensing the chromatin for transcription. Neither Acetyl CoA, nor
sodium butyrate, nor Gal4-VP16 affected splicing of the pre-synthesized pre-mRNA (S4C Fig,
lanes 2–6). We also verified that the ratio between extract and either naked or chromatinized
template had no effect on splicing. These experiments indicated that levels of transcription did
not affect the efficiencyof the splicing reaction (% of splicing), and also that increased concen-
tration of chromatin constituents did not have any inhibitory effect on splicing (S4D Fig).
From these validation experiments, we concluded that our conditions properly emulated chro-
matin-decondensation associated with co-transcriptional splicing.
Interestingly, our in vitro assay showed that the transcription of a chromatinized template
leads to pre-mRNA splicing that is less efficient than that detected using a naked DNA tem-
plate (Fig 4C, compare lanes 7–9 and 16–18, with 30% vs. 10% splicing efficiency).This obser-
vation is the first evidence for a direct effect of chromatin on splicing efficiency.
To gain insight in the mechanism behind this impact of chromatin on splicing efficiency,
we investigated whether the effect was co- or post-transcriptional. To that end, in vitro reac-
tions with the Gal4-E4-Ftz minigene were supplemented with α-amanitin after 45 min of tran-
scription and either stopped (ice) or incubated for another 75 min at 30°c (chronogram Fig
4D). The α-amanitin blocks RNAPII processivity without directly affecting splicing (S4C Fig,
compare lanes 4 and 6). As expected from the previous experiments, splicing during the first
45 min (phase of transcription and splicing) was less efficient when using the chromatinized
template (undetectable vs. 27%—Fig 4E, compare lanes 3 and 7). Interestingly, decreased effi-
ciency of splicing as a consequence of chromatin was also observedpost-transcriptionally after
the addition of α-amanitin (phase of just splicing—Fig 4E, compare lanes 4 and 8). Chroma-
tin-dependent reduction in post-transcriptional splicing efficiencywas also observedwhen
using two additional reporters where Ftz exons 1 and 2 were separated by exons harboring (S)
or not (T) 3 copies of an SF2-binding sites (S4E Fig, compare lanes 2 and 6, and 8 and 12).
displaying the percentage of inclusion for six alternative exons previously described as sensitive to U2 snRNP activity [18].
Exon inclusion was detected by radiolabeled RT-PCR (S3D–S3FFig) using total RNA of HeLa cells depleted for the indicated
chromatin factors and controls. Graphs display effects obtained from triplicateexperiments; asterisks indicate p-val<0.05. The
stippled line shows the percentageof inclusion for untreated and siGlo-transfected cells, while the exons amplified by
RT-PCR are drawn on the top of each graph.
doi:10.1371/journal.pgen.1006318.g003
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Fig 4. Chromatin affects the efficiency of intron removal in vitro. (A) Diagram of the three different sources of Ftz reporterRNA
used to study in vitro the impact of chromatin on splicing. (i) A capped pre-mRNA that was independently transcribed with the T7
RNA polymerase before being added to HeLa nuclear extract; (ii) pre-mRNAwas transcribed in HeLa nuclear extract froma
naked, or (iii) a chromatinized DNA template. Regardless of the source, the pre-mRNAsare identical, with two exons and one
intron originating from theDrosophila Ftz pre-mRNA. (B) Analysis of the products of in vitro splicing of the pre-synthesized RNA
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These constructs where the S sequences lead to full inclusion of the intervening exon, while the
T sequences results in its exclusion, were also an opportunity to observe that chromatin is
unable to override a decision enforced by SR proteins (S4E Fig, species a and c). Altogether,
these experiments indicate that the pre-mRNPs generated from the naked and chromatinized
templates were not equally competent for splicing. This strongly suggests that chromatin influ-
ences the quality of pre-mRNPs assembled co-transcriptionally, which in turn affects the effi-
ciency of splicing. Yet, our observations also suggest that chromatin is involved only in fine-
tuning of splicing, with little impact on the effect of splicing enhancers.
Discussion
Co-transcriptional removal of introns occurs in the vicinity of other gene expression machiner-
ies, including the RNAPII and the chromatin remodeling factors. While the impact of the
RNAPII is now well documented, a role for chromatin in the regulation of splicing is sustained
mostly by correlative observations, and the mechanisms involved remain unclear. Here, we
have provided a comprehensive study of the coupling between chromatin and splicing, and we
have established an in vitro system to examine this coupling directly. Although we have at this
point examined only a limited number of reporter constructs, our data indicate that transcrib-
ing pre-mRNA from a chromatinized template influences splicing efficiency, and we propose
that this effect is in part mediated by physical interactions between chromatin factors and the
spliceosome.
Our RNAi screen identified a surprisingly broad range of factors, rather than a specific sub-
set of chromatin complexes. The screen caught nearly every chromatin factor previously
reported to modulate splicing (SWI/SNF, Cbx3/HP1γ, ZMYND11/BS69, CHDs. . .), support-
ing the relevance of the hits. Some of these factors, including Cbx3/HP1γ, and ZMYND11/
BS69 have been examined for their genome wide effect on splicing, further suggesting that our
hits affect exons beyond those examined during the phase of validation [4,23]. These genome-
wide studies and others on MBD3 and CHD4 also indicate that these chromatin factors only
have minor effects on the expression of splicing factors, including SRSF1, SRSF3, SRSF4,
SRSF5, SRSF6, and hnRNPA1 [24,25].
A reasonable explanation for the diversity of the hits is the presumed heterogeneity of the
local levels of chromatin compaction and/or the range of histone modifications surrounding
each copy of our integrated splicing reporter, like it has for example been described for the vari-
ous copies of endogenous histone genes (The Encode Project Consortium). In that sense, our
screenmay serendipitously have probed a large spectrumof chromatin environments influenc-
ing the regulation of splicing. The local influence of chromatin was also illustrated by our
reporter (lanes 1–3), of a transcription/splicing reaction transcribing the RNA reporter from a naked DNA template (lanes 4–5), or
from a chromatinized template (lanes 6–7). Transcription/splicing was assayed in the absence (-) or in the presence (+) of
Gal4-VP16. For each condition, the RNAwas resolved on a 6% denaturingpolyacrylamide gel; the relative abundance of spliced
mRNA indicated at the bottomof each lane was calculated as follows: % splicing = [spliced/(unspliced+spliced)]. The asterisk
indicates the labeling of U6 snRNA by a terminal uridylyl transferase present in HeLa nuclear extract [15,46]. (C) The influence of
NaB and CoA on in vitro transcription/splicingwas evaluated in reactions assembled with naked or chromatinized DNA template.
The presence (+) or absence (-) of Gal4-VP16, NaB, CoA and the time of incubation are indicated above the gel. The transcription
level was calculated as the sum of unspliced and spliced RNA, and lane 4 was arbitrarily set at 100%. The splicing efficiencywas
calculated as in Fig 4B. (D) The experimental procedure applied in Fig 4E is displayed with a chronogram. (E) Chromatin affects
the quality of pre-mRNP released by RNAPII transcription. The transcription/splicing reactions of naked or nucleosomal template
were performed for 45 min (lanes 3 and 7) or 120min (lanes 1, 2, 4, 5, 6, 8). α-amanitinwas added to the reactions after 45 min of
incubation (lanes 4 and 8) and the reactionswere extended for additional 75 min. The presence (+) or absence (-) of Gal4-VP16 is
indicated. The percentageof splicing (% splicing) was calculated as in (B) for lanes 2 and 6; while the percentageof post-
transcriptional splicing in lanes 4 and 8 was calculated as followed: % PT splicing = [(spliced120-spliced45)/(unspliced+(spliced120-
spliced45))].
doi:10.1371/journal.pgen.1006318.g004
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validation experiments on endogenous genes. These experiments showed that depending on
the exon under scrutiny, a given chromatin factor had a variable effect, favoring either exon
inclusion or exclusion in a rather unpredictable manner. This is in agreement with an earlier
study showing that in human breast cancer MCF7 cells, the HDAC inhibitor TSA and the
DNA methylase inhibitor 5azadC promote the inclusion exon E107 of the SYNE gene, while
they induce exclusion of exon E33 of the fibronectin gene [26]. Likewise, in Drosophila S2 cells,
depletion of SWI/SNF subunits promotes the use of proximal splice sites at some genes, while
it favors distal sites at others [27]. A possible source of heterogeneity in the chromatin of exons
may be their degree of proximity with promoters and enhancers, caused by DNA looping [28].
The deciphering of the probably very complex combination of regulatory signals at play at a
given locus will be required to meet the challenge of anticipating the per gene impact of a chro-
matin factor on splicing.
Our proteomic approach confirmed that the splicing machinery is physically bound to a
subset of chromatin factors when spliceosome complexes are assembled in vivo. Some of these
factors were previously connected to splicing, includingMORF4L2 (close homologMRG15),
Cbx3/HP1γ, SMARCA2/BRM, EHMT1 and EHMT2, EZH2, and multiple HDACs [2–4,29–
31]. In several earlier proteomic studies of the splicing machinery, such interactions were not
detected, or were limited to a few factors. This is likely rooted in the procedures used for purifi-
cation as these approaches involved characterization of the splicing machinery assembled de-
novo on pre-synthetized reporter RNAs. With such a setup, components normally dispensed
during transcription will not be loaded onto the spliceosome. Our procedure based on
U2-snRNP anchoring overcomes this limitation and allows for the isolation of both de-novo-
and in-vivo-assembled spliceosome complexes. In that sense, it resembles the previously
described capture of the PRPF40A-U2 snRNP that revealed the presence of CHD4/8 and sev-
eral SWI/SNF subunits in addition to splicing factors [8]. Among the 15 remodeling factors
present in that complex, 13 were also detected by our approach.
The U2 snRNP is one of the best-characterized snRNPs of the spliceosome, and while sev-
eral versions have been described, corresponding to different maturation stages [32], it is likely
that only the most abundant particles have been characterized so far, excluding those associ-
ated with the transcribed chromatin. Historically, both genetic and biochemical studies have
considered the snRNPs as essential rather than regulatory components of the spliceosome.
Recent studies, however, demonstrated that several alternative splicing events are regulated by
the levels of core components of the splicing machinery [18,33]. The exons we examined to val-
idate our hits were identified as particularly sensitive to levels of U2-snRNP. We speculate that
this snRNPmay function as a mediator between the splicing machinery and the local chroma-
tin environment, and that exons sensitive to U2-snRNP activity are also likely to be subject to
chromatin effects.
Finally, we note that the list of “chromatin factors” physically linked to the spliceosome in our
proteomic approach actually included histones. This suggests that these primary building blocks
of chromatin may impact on the outcome of splicing, possibly by affecting nucleosome assembly
when present in limited supply. Indeed, nucleosomesmay be involved in exon definition as sug-
gested by the elevated nucleosome occupancy/positioningobserved in exons compared to introns
(for a review, see [34]). Nucleosome assembly may also be relevant for RNAPII elongation rate
and for the formation of loops connecting alternative exons to promoter-positioned nucleosomes
[28,35]. In this context, we believe that our in vitro system combining chromatin, transcription,
and splicing will provide a powerful tool to unravel the molecular network linking histones to
spliceosome components during the course of transcription.
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Materials andMethods
RNAPII transcriptionand splicing assay
DNA templates containing promoter and reporter were generated by PCR, purified and 40 ng
of DNA were added to a 15-μl in vitro transcription/splicing reactions. Assays were performed
by mixing 5-μl of HeLa nuclear extract (NE) prepared as described [19], 5-μl of transcription/
splicing mix and 5-μl template, then incubation at 30°C. Transcription/splicing mix was assem-
bled for each reaction with 0.20 μl 32P-UTP (3000 Ci/mmol), 0.5 μl 25× ATP/CP mix (12.5
mMATP, 0.5 mM creatine phosphate (di-Tris salt)), 0.5 μl MgCl2 (80 mM), 0.75 μl Hepes-
KOH (0.4 M), 0.1 μl dNTP (1 mM), 0.5 μl 25× NTP mix (0.2 mMUTP, 0.6 mMGTP, 3.75
mMCTP and ATP), 0.05 μl sodium butyrate (400 mM), 0.05 μl acetyl coenzymeA (1 mM),
and H20 up to 5-μl. To activate transcription of template containing GAL4 promoter, the NE
was supplemented with 20 ng of recombinant Gal4-VP16, while to inhibit transcription 200ng
of α-amanitin was added per reaction. The dNTP/NTPmix is not required, but in our hands, it
significantly increased the efficiencyof transcription and removed some unspecific bands asso-
ciated with DNA synthesis. In vitro splicing of pre-mRNA templates was carried out like for
transcription/splicing assays.
Plasmid constructions
To construct the Ftz splicing reporter, a fragment containing exon 1 (256 bp), intron 1 (147 bp),
and exon 2 (186 bp) was amplified by PCR from the DoF1 plasmid [19], and insertedHindIII/
XbaI in pcDNA3.1(+) downstream of a CMV promoter. The GAL4-E4-Ftz constructs were gen-
erated by replacement of the CMV promoter between theMluI and HindIII restriction sites. To
generate the derivative constructs with exon T or S, a ClaI restriction site was created in the
intron of constructsmentioned above and PCR fragments containing the respectiveDUP exons
[36,37] bordered by a small part of the intron were cloned into the ClaI restriction site. The DNA
templates for transcription/splicing assay were amplified by PCR using the universal primers
CTTAGGGTTAGGCGTTTTGCGCTGand CAACTAGAAGGCACAGTCGAGGCTG.
The luciferase splicing reporters v4-v5–ren and int-ren were inserted into the ecdysone-
inducible vector pI-TK Hygro (kindly provided by R. Karni, Hebrew University Medical
School–Jerusalem, Israel) between the restriction sites HindIII and XhoI (ligated cohesively
with SalI). Cloning of these reporter constructs requiredmultiple steps; in brief, the first two
ATG codons of Renilla cDNA were removed, an exogenous intron with or without the v4-v5
genomic part of the human CD44 gene was inserted, and finally an IRES and the Firefly lucifer-
ase cDNA were inserted downstream of a Renilla cDNA. The details of each construct are
available upon request. The pBabe-FV5-U2-B” construct was generated by inserting a U2-B”
cDNA into the pBabe vector downstream of Flag and V5 tags [38].
Chromatin assembly andMNase footprint
DNA template were chromatinized as described in [39] using the Chromatin Assembly Kit
(Active Motif). The chromatinized DNA was digested with MNase as described in [39] for 0,
30, 75 and 150 sec and analyzed by agarose gel electrophoresis/ethidium-bromide staining.
Mass spectrometryand antibodies
The HeLa S3 cell line expressing FV5-U2-B” was generated by viral infectionwith pBabe-
FV5-U2-B” and a clonal cell line stably expressing the tagged protein at a high level was
selected by immunofluorescence using anti-V5 antibody (Invitrogen) and expanded to prepare
nuclear extract. Endogenous PP2Cγ hnRNPA1 and U2-B” levels were estimated by western
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blotting with monoclonal antibodies 7–53, 4B10 and 4G3, respectively [38]. U2 snRNP was
immunopurified from fresh NEB” nuclear extract using ANTI-FLAGM2 Affinity Gel, then
eluted with the 3× FLAG Peptide (Sigma-Aldrich), and resolved on a 15–35% glycerol gradient
as described [40]; the proteins and RNAs were analyzed on SDS-PAGE and urea gels respec-
tively. Immunoprecipitations from in vitro splicing reactions were performed as above, but the
enrichedRNAs were isolated directly from the beadswithout elution. To enrich spliceosome com-
plexes, in-vitro-splicing reactions (1 ml) were set up in the presence of ATPγS [15] and by using
the AdML pre-mRNA reporter transcribed from the DoA1 plasmid [19]. The reactions were next
size-selectedon a Sephacryl-S500gel-filtration column (approx. 106 to 5.106 Da) to resolve com-
plexes assembled onto the radiolabelled splicing reporter [41]. The pooled fractions corresponding
to each complex were incubatedwith anti-FLAGM2 AffinityGel and the immunopurified factors
were analyzed by mass spectrometryas described [42].Western-blot analysis was carried out with
the following antibodies: anti-SF3a120, 66, 60 (gift fromA. Krämer, Department of Cell Biology,
University of Geneva, Switzerland); anti-U2AF65 [42]; anti-U2-B” (mAb 4G3); anti-eF4A3 [43];
anti-hnRNPC1/C2 (mab 4F4); anti-hnRNPA1 (mAb A1/55); anti-CBX3 (mAb 1G6); anti-CHD4
(Sigma,WH0001108M1); anti-SMARCC1 (Sigma, B5186); anti-SMARCA4 (mab1E1); anti-
SMARCA2 (mab4147); anti-PHC1 (Sigma,HPA006973).
RNA purificationand RT-PCR
The RNA samples were prepared as described [44] and the cDNA libraries were synthesized
with M-MLV reverse transcriptase using oligo dT priming or random primers. Radioactive
PCRs were performed using 5’end-labeled primers. The primers used in this study are available
upon request.
siRNA screen of chromatin factors and cell culture
The siRNA library was acquired fromQiagen (each siRNA is listed in S2 Table). The Human
Sam68 siRNA (CGGATATGATGGAT GATAT;[45] and siGlo (Dharmacon) were used as con-
trols. 293EcR and HeLa cells were transfected with Lipofectamine RNAiMAX (Invitrogen).
Regarding the siRNA screen conditions, 104 293EcR v4-v5-ren cells were transfected with the
siRNA (25 nM final concentration) in 96-well plates. 60h after transfection, expression of the
reporter was induced with Ponasterone A (1 μM final concentration) for 16 h and then the
cells were lysed in the following buffer (100 mM Tris (pH 8), 0.5% v/v Nonidet P-40, 10 mM
DTT). Renilla and Firefly luciferase activities were measured with a Dual-Glo Luciferase assay
system (Promega) using a FLUOstar OPTIMAmicroplate reader (BMG Labtech).
Recombinant protein purification
Recombinant Gal4-VP16 was produced in bacteria, and then first enriched using a histidine
tag, followed by ion-exchange chromatography using a SP-FF Hitrap, and finally gel-filtration
chromatography with a Superose 12 column.
Supporting Information
S1 Fig. Related to Fig 1: Analysis of protein and RNA components associatedwith the puri-
fiedU2 snRNP. (A) Protein analysis of the U2 snRNP (12S and 17S) immunopurified via FV5-
U2-B” from the NEB” nuclear extract. The U2 snRNPs was resolved on a 10–30% glycerol gra-
dient and the proteins corresponding to fractions labeled in S1B Fig were analyzed in
SDS-PAGE stained by Coomassie-blue. Individual proteins were identified by comparison
with earlier work [29] and their presence was confirmed by proteomic analysis of spliceosome
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complexes (S1 Table). (B) RNA associated with the U2 snRNP immunoprecipitated with FV5-
U2-B”, eluted with Flag peptides and loaded on a glycerol gradient was analyzed by separation
on a 7% denaturing polyacrylamide gel and stained with ethidium bromide (lanes 1–16). The
input RNAs contained in NEB” were also analysed to estimate the enrichment of U2 snRNA
after purification of the snRNP. The twomain peaks of U2 snRNA detected in the gradient cor-
respond to the 12S and 17S forms of the U2 snRNP (lanes 3–6 and 7–10). (C) Analysis of splic-
ing products associated with the Flag-taggedU2 snRNP incorporated into spliceosomes de-
novo-assembled. Splicing reactions were assayed with AdML pre-mRNA in NE (lanes 1–5) or
NEB” (lanes 6–10) and analyzed by gel electrophoresis and autoradiography. (D) Proteins pres-
ent in fractions obtained after gel filtration like in Fig 3C were precipitated and separated in
SDS-PAGE to analyze them by western blot using specific antibodies detecting CHD4,
SMARCC1, SRSF6 and U2-B”. (E) Western blot analysis of several chromatin factors (CHD4,
SMARCC1, SMARCA4, SMARCA2 and PHC1) for their co-immunoprecipitation with U2-B”
from spliceosome and H gel filtration fractions.
(PDF)
S2 Fig. Related to Fig 2: Analysis of luciferase splicing reporters in 293-EcR cell lines. (A)
Several amplicons corresponding to various portions of bicistronic transcript expressed by the
two splicing reporters were amplified by radioactive RT-PCR (lanes 1–6). Expression of exons
v4-v5 was only detected in the 293-EcR v4-v5-ren cells, while the Firefly luciferase transcript
was specifically amplified in the two reporters cell lines (compare lanes 1–4 with 5 and 6). The
amount of amplified transcripts reproduces the levels of luminescence detected for each
enzyme (S2B Fig), supporting the correlation between the transcript levels and the lumines-
cencemeasured. Two endogenous regulators of exons v4-v5 were also detected as controls to
show the absence of a significant effect of ponA on their transcript level. (B) Relative Renilla
and Firefly luminescence detected in 293-EcR cell lines, in absence (-) or presence (+) of ponas-
terone A (ponA) to induce reporter expression. The uninduced 293-EcR v4-v5-ren cells dis-
played leaky transcription but remained inducible. (C) Depletion of Sam68 decreases splicing
of v4-v5 exons and reduces Renilla luminescence. An unrelated siRNA (siGlo) was transfected
as control. (C, left panel) Knockdown of Sam68 specifically reduces the expression of Renilla
luciferase. Splicing efficiencywas calculated as the ratio between both luciferases. (C, right
panel) The efficiencyof v4-v5 splicing was estimated by radioactive RT-PCR and bands were
quantified with a PhosphoImager (graph on top). (D and E) Validation of individual siRNAs
targeting the hits of group A. Each siRNA was transfected into the clonal 293-EcR v4-v5-ren
cells and its effect on luciferase activities and splicing of exogenous v4-v5-ren was evaluated by
luminescence and RT-qPCR, respectively. Unspliced and spliced v4-v5 exons were both ampli-
fied in the same RT-qPCR reaction and the level of each product was obtained by measuring
SYBR-green incorporation in the linear range of the PCR.
(PDF)
S3 Fig. Related to Fig 3: Assessment of splicingmisregulation for endogenous genes after
depletion of chromatin factors in HeLa cells. (A) The efficiencyof gene silencing using spe-
cific siRNA was assessed by RT-qPCR using as control samples untreated or treated with siGlo.
(B) Percentage of exon v4-v5 splicing displayed in Fig 3A. The percentages and standard devia-
tions (Stdv) were derived from three independent experiments. The red discontinuous line
shows the splicing percentage of exons v4-v5 in untreated and siGlo treated cells. (C) Analysis
for splicing of exon v4-v5 in HeLa cells treated with several siRNA targeting chromatin factors
retained as hits (CHD7, CHD5, POLE3) or unselected in our screen (CBX8, HDAC3 and
NCAPD2). The efficiencyof siRNAs for each factor is displayed in the top, while the percent-
age of exon v4-v5 splicing is presented at the bottom. (D and E) RadiolabeledRT-PCR was
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used to examine the inclusion of exons reported as sensitive to U2 snRNP activity. PCR products
were separated in undenaturing acrylamide gel, then dried and exposed for their detection by
phosphoimager. A draw on the right of each gel displays the exons composition associated to
bands. (F) Similar analysis to D and E but applied to RAC1, PSMG1 and hnRNPU constitutive
exons. (G) The effect of the chromatin factors on splicing cannot be correlated with their effect on
the expression of the splicing regulators SRSF1, SRSF3, SRSF4, SRSF5, SRSF6 and hnRNPA1. Left
panels: putative binding sites for SRSF1, SRSF5 and SRSF6 within the indicated exons; the binding
sequences and their mapping within the exons were obtained using ESEfinder 3.0 (http://rulai.
cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home). Right panels: levels of indicated splic-
ing regulators was quantified by RT-qPCR after knock-downof each of the chromatin factors
examined in Fig 3A. Fold-change was then calculated relative to siGlo and plotted as a function of
the effect of the chromatin factor on splicing. The scatter plots show an absence of correlation
between splicing regulator expression and inclusion of exons showed in samples of Fig 3.
(PDF)
S4 Fig. Related to Fig 4: In vitro transcription-splicing system using chromatinized tem-
plates. (A) Diagram of RNA and DNA reporter templates with two exons. (B) MNase footprint
analysis of an in vitro-assembled polynucleosomal DNA template. DNA markers, mono- and
multimers of nucleosome are indicated. (C) Gal4-VP16, NaB/CoA, and α-amanitin were evalu-
ated for their influence on the regulation of splicing, independently of their role in transcrip-
tion. They were added to in vitro splicing reactions (lanes 3–6) with the RNA version of the
reporter for 120 or 45 min as indicated. Then, the percentage of splicing was compared to the
basic conditions (lanes 1, 2). (D) Various amount of naked or chromatinized templates were
added in transcription-splicing reactions in order to assess potential splicing variation brought
by templates. On the top of gel, the quantity of templates added in each reaction is reported,
while the percentage of splicing calculated as in the Fig 4B is displayed at the bottom. All reac-
tions were designedwith the GAL4-E4-Ftz reporter. (E) Similar experiments to the Fig 4E were
performed using two other reporters containing 3 exons. The reporter S integrates three copies
of an ESE bound by SRSF1 in its central exon, while the reporter T inserted three sequences
inactive for splicing. A precise description of S and T sequences could be found in (Labourier E
et al., 1999-NAR [36]). The splicing percentage were calculated as in Fig 4E.
(PDF)
S1 Table. Related to Fig 1: Mass-spectrometrydata of splicing factors.Table organized as in
[44].
(PDF)
S2 Table. Related to Fig 2: Libraryof siRNAs used to screen chromatin factors.
(PDF)
S3 Table. Comparing the outcome of the siRNA screen and that of the proteomic of the U2
snRNP with the outcome of the siRNA screen describedby Salton et al. [17].Chromatin fac-
tors identified in both screens are highlighted in yellow; Non-overlapping siRNAs are
highlighted in red or green.
(PDF)
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